Children's Mercy Hospital (MO)

DIVISION DIRECTOR - ENDOCRINOLOGY CHILDREN'S MERCY KANSAS CITY, MO The Department of Pediatrics at Children's Mercy seeks a creative and scholarly leader to serve as Division Director of Endocrinology. The Division Director will be responsible for leading the clinical, educational, research and quality missions of a comprehensive academic endocrinology program. Likewise, the Division Director will foster collaborative ties with the whole of the pediatric enterprise to ensure the welfare and improve the health of the children in the region. This is a clinical faculty position offering academic appointments at the University of Missouri - Kansas City School of Medicine and the Kansas University School of Medicine, rank to be commensurate with experience. The foremost quality necessary for this position is vision for the field of endocrinology. Other desired characteristics include 1) a track record of developing young clinicians into future leaders in pediatrics; 2) interest in section academic infrastructure and finances; 3) experience in a high volume, diverse endocrinology service; 4) successful collaborations with administration, hospital and medical partners in managing endocrinology's workflow while maintaining the highest value of care; and 5) developing a culture of high team accountability and professionalism. The individual selected for this position will be a strategic and highly communicative leader who is a MD/DO or MD/DO/PhD and who is board certified in pediatric endocrinology. As Endocrinology Division Director, the individual reports to the Chair of Pediatrics. The Division of Endocrinology and Diabetes at Children's Mercy Kansas City is one of the largest in the country. Our team is comprised of more than 120 members and includes 29 pediatric endocrinologists, 5 nurse practitioners, registered nurses, certified diabetes educators, registered dieticians, psychologists and social workers. We provide endocrine care to more than 12,000 children in the region; in the past year, we have seen more than 26,000 patients across all our outpatient centers including several sites in the Kansas City metropolitan area as well as multiple distant sites in Missouri and Kansas. Our clinical program cares for children affected by general endocrine disorders and for those diagnosed with diabetes mellitus. Our Diabetes Center was the first pediatric program in the United States to be accredited by the American Diabetes Association and today cares for nearly 2,400 children diagnosed with Type 1 and Type 2 diabetes. Furthermore, our clinicians are actively involved in treating children with rare conditions who need a focused, multi-disciplinary and comprehensive approach. Our specialty clinics include: The Great Heights (Turner Syndrome) Clinic The 2 Clinic The GPS (Gender Pathway Services) Clinic, where we provide services to transgender children and adolescents. The GUIDE Clinic, where care is provided to children with Disorders of Sexual Differentiation) The Multispecialty Adolescent PCOS Clinic The Thyroid Nodule and Carcinoma Clinic The Prader-Willi Clinic The Endocrine Disorders in Cancer Survivors (EDICS) Clinic Type 2 Diabetes Prevention Clinic About Children's Mercy Children's Mercy is one of the United States' leading non-profit, independent pediatric health systems, offering a comprehensive suite of departments, centers, and clinics. Founded in 1897, Children's Mercy is dedicated to holistic care, impactful research, breakthrough innovation and educating the next generation of caregivers. Guided by our mission, vision and values, our aim is to create a world of wellbeing for all children. Children's Mercy is consistently ranked among the best children's hospitals in the nation by US News & World Report, and we were the first hospital in Missouri or Kansas to receive Magnet designation for excellence in patient care from the American Nurses Credentialing Center - an honor we have received five consecutive times. Some Children's Mercy facts and figures: 390 licensed beds Nearly 800 faculty >50 specialties 600,000 total visits 190,000 emergency and urgent care visits 20,000 surgical cases Primary service area encompasses 150 counties in Missouri and Kansas Level 1 Children's Surgery Center by the American College of Surgeons Only pediatric Level 1 Trauma Center between St. Louis and Denver Comprehensive solid organ transplant center with sustained, exceptional outcomes Education Education is a core tenet of Children's Mercy. Children's Mercy provides education opportunities to nursing students, medical students, residents and fellows, supporting over 1,400 learners annually. Children's Mercy is the pediatric clerkship site for both UMKC and KU medical students, and provides elective rotations and sub-internships to students at any accredited allopathic or osteopathic medical school. Children's Mercy is highly active in Graduate Medical Education with accredited residencies in pediatrics, med/peds, child neurology, pediatric dentistry, pediatric optometry and pharmacy. Children's Mercy offers more than 40 fellowship programs across numerous areas, developing the next generation of subspecialists. Certificate and masters programs are also operated in conjunction with its academic partners, the University of Kansas (KU) and the University of Missouri - Kansas City (UMKC). Finally, our robust clinical training resources are augmented by research opportunities for learners at all levels. Research Children's Mercy is dedicated to becoming a leader in pediatric research. A directed strategic planning initiative established the Children's Mercy Research Institute (CMRI) to focus on research and research infrastructure. Through the generosity of two philanthropic gifts totaling $150 million, the hospital constructed a nine story, 375,000 square foot facility provide scientists state-of-the-art technology. In addition, these generous gifts help support funding for scientific programs and recruitment. Research conducted today includes basic science and clinical research in numerous areas including pharmacology, cancer, cardiology, genetic diseases and health outcomes. Areas of research strength include Precision Therapeutics, Genomic Medicine, Population Health, Emerging Pathogens and Innovations in Health Care Delivery. Beyond these areas of emphasis, Children's Mercy and the CMRI also provide encompassing resources for Children's Mercy faculty to pursue research, from developing a research question, biostatistical planning, grant application and management, and coordination of clinical trials. About Kansas City: Straddling both Missouri and Kansas, the Kansas City Metropolitan Area is an affordable and comfortable place to live and raise a family. The metro's anchor city, Kansas City, Missouri, is the largest city in the state and has great museums, a busy downtown, multiple professional sports franchises, an exciting music scene and many charming neighborhoods. Throughout the Metro area, you will find highly ranked public schools, beautiful parks and other green spaces, and lots of amazing people. Kansas City is large enough to provide the amenities of a metropolitan area, while small enough to allow for easy commutes, assessable amenities and a very high quality of life. Ideal Qualifications and Experience An MD or equivalent and board certification in pediatric endocrinology is required A strong record of clinical and academic achievement Demonstrated interest in advancing medical education, patient care and research A commitment to our true north pillars: quality and safety, people, patient experience, delivery and stewardship Fosters and models our values: kindness, curiosity, inclusion, team and integrity A deep commitment to fostering and supporting programs that address equity, inclusion and diversity A track record of partnership with academic medical centers Experience with or a desire to learn and utilize LEAN methodologies Strong interpersonal skills and the ability and commitment to collaborate with leadership at partner institutions Nominations and Applications (cover letter and curriculum vitae) should be submitted via e-mail: Attention: Drs. Kim Hartman and Bryce Heese, Search Committee Co-Chairs All materials will be treated as confidential. Children's Mercy is an Equal Opportunity/Affirmative Action Employer. For additional information, please visit our website at .

About this Opportunity The Phase I / Experimental Therapeutics Program Director in the Children's Mercy Cancer Center (CMCC) will lead a multi-disciplinary team of professionals focusing on early phase clinical trials and new drug discovery in childhood cancer. The Director will oversee and set the vision for clinical, research, and education development while pursuing and securing funding to support these efforts. The Director will: maintain and expand the national Phase I consortia membership for the CMCC; mentor and support faculty and trainee participation; and work with hospital leaders to align the vision and direction the Phase I program with that of the Section, Division, and Hospital. The Phase I / Experimental Therapeutics Program in the Children's Mercy Cancer Center has been enrolling patients since 2010. Clinical trials available in the program have been a mixture of academic consortias including expanded COG Phase 1+ trials, direct Pharma-sponsored trials, and local investigator initiated trials. CMCC's Phase I program is closely partnered with the hospital's Pediatric Clinical Pharmacology program, one of the largest in the country. The program has had 3 Hematology/Oncology faculty closely involved in the program's trial and patient oversight and this is anticipated to grow. The Phase I program is well supported with a dedicated Advanced Nurse Practitioner and 4 clinical research coordinators. In addition to the Clinical Pharmacology core laboratories, the Phase I program has direct access as a full NCI-designated Cancer Center consortium member with the University of Kansas Cancer Center's Phase I program and its nationally recognized drug discovery program located just a few miles away in Kansas City, KS, and as well the KU School of Pharmacy on the nearby Lawrence, KS campus. CMH faculty are embedded in numerous labs within the KU Cancer Center. Faculty appointments will include membership within the KU Cancer Center. Requirements Pediatric Hematology/Oncology board certified MD, MD/PhD, or equivalent degree Associate or Full Professor rank or eligibility required Experience in Phase I trials required with one or more of the following preferred o serving as local PI for Phase I trials, o experience as Study Chair of a Phase I or I/II trial o track record of academic productivity in Phase I trials Preference given for individual with one or more of the following o Clinical Pharmacology training, PhD or Pharm D degree in addition to MD or DO degree, and/or o Experience in pre-clinical drug discovery research o Grant supported research o Participation in national Phase I consortia o Phase I leadership roles in other institutions or pharma industry COG membership, particularly if participant in Phase I or II COG trial committees either sponsored by the Phase I committee or by a Disease committee Salary and academic range are commensurate with experience. Qualified candidate should submit their CV to EEO Employer / Disabled / Vet

The Clinical Genetics and Genomics Laboratory in the Department of Pathology and Laboratory Medicine at Children's Mercy Kansas City, one of the world leaders in genomic analysis, is excited to announce an opening of an Assistant Director to join our growing team in providing state of the art clinical testing for the diagnosis of rare pediatric disease. Qualified candidates must have experience with exome / genome analysis, as well as competency in sequence and copy number variant interpretation and reporting from next generation sequencing data. Academic appointments are available through the University of Missouri - Kansas City School of Medicine. Required qualifications include a PhD or MD/DO degree, as well as ABMGG board certification, or active candidate status in Molecular Genetics or Laboratory Genetics and Genomics. The individual selected for this position will: work closely with our growing team in the interpretation and reporting of genomic testing, including next-generation sequencing of panels, short read genome sequencing, long read genome sequencing, and other molecular tests work as a team on test development and validation, new product launch, process improvement, and clinical research serve as a consultant to ordering physicians and clients monitor quality control and assurance at all levels of practice participate in the education of students, residents, fellows, faculty, and staff support Children's Mercy's mission to improve the health and wellbeing of children by providing comprehensive, family-centered health care and commitment to research, academic and service excellence Our translational work is enabled by close collaboration with The Genomic Medicine Center (GMC). The GMC consists of board-certified scientists in clinical molecular and cytogenetics, physicians, researchers, genetic counselors, bioinformaticians, software engineers and clinical laboratory scientists experienced in genomic analysis. On-site state of the art instrumentation includes Illumina NovaSeqX Plus, 5 PacBio Revio instruments, and BioNano Saphyr. Our ABMGG accredited fellowship program in Laboratory Genetics and Genomics currently has two fellows in training. Remote work opportunity is subject to discussion. Please apply with CV and Cover Letter using link below or send to . The successful applicant must share our unwavering commitment to excellence, integrity, collegiality, antiracism, and respect for inclusion of individuals with diverse backgrounds.

The Department of Pediatrics at Children's Mercy seeks a creative and dynamic leader to serve as Division Director of Infectious Diseases at the rank of Associate Professor or above. The Division Director will lead a talented team of clinicians, researchers, and educators. Responsibilities include leading the clinical, research, educational, and quality objectives of the division. Candidates should have a vision of the future of pediatric infectious diseases, be mission driven, and possess evidence of previous leadership experience. Other desired characteristics include 1) a track record of scholarly productivity; 2) history of mentorship that includes developing postdoctoral fellows and junior faculty members; 3) clinical or research finance experience; 4) successful collaborations across subspecialties and disciplines; 5) unwavering commitment to the principles of diversity, equity, and inclusion; and 6) commitment to developing a culture of innovation and team connection. The division includes 12 MD/DO faculty members (many of whom have additional roles across the organization), 4 advanced practice providers, 3 postdoctoral fellows, 2 pharmacists, part-time PhD statistical support, and division administrative support. All pediatric residents complete an ID rotation during their 2nd year of training or 4th year for Med/Peds. This dynamic division provides inpatient consultations across 3 clinical services. The general ID and immunocompromised (IC) services care for children at the main Adele Hall campus, and a third service consults on patients at our community sites CM Kansas and the University of Kansas (KU). Approximately 2,000 consults are seen between the general and IC services at the main campus annually, with an additional 60 across the community sites. Ambulatory clinics include general ID, international travel, adoption, penicillin allergy delabeling, special immunology, and fellows' clinic. As one of the first hospitals in the country to create an Antimicrobial Stewardship Program (ASP), the ASP team has been on the forefront of innovative stewardship work clinically as well as generating new knowledge about stewardship practices. In the past 10 years, the division has added a robust ambulatory ASP presence, working in collaboration with the two emergency departments, and three urgent cares in the CM system as well as affiliated pediatric practices using quality improvement methodology to reduce diagnostic testing and antibiotic overuse. Creating new knowledge through research is an important and large part of the work of this division with federal, foundation, and industry grants and contracts supporting basic, translational, clinical, and quality improvement research with grants totaling more than $11 million for FY25. The research interests are broad and include neonatal Escherichia coli infections, severe adverse drug reactions, school and community-based respiratory virus epidemiology, and clinical trials assessing new vaccines and medications, and epidemiology of respiratory and gastrointestinal viral infections in collaboration with the Director of Clinical Microbiology and Molecular Infectious Disease Laboratory. CM is also a hub site for the Pediatric Pandemic Network, with members of the division focusing on preparation and research-based pediatric care in emergencies, disasters, and pandemics. Creating an environment that fosters learning through trainee centric education is a primary focus of the ID division. In addition to a successful long-standing postdoctoral fellowship program, the ID division provides clinical education to all second-year categorical pediatric residents, fourth year combined internal medicine-pediatric residents, hospital medicine fellows, and internal medicine ID fellows through consult rotations. An advanced ID elective is also available for interested trainees. Didactic education is provided throughout the academic year for all residents. Medical student electives are also available. The ASP team has created a stewardship track for fellows interested in antimicrobial stewardship focused careers, in addition to a wide variety of research and quality improvement opportunities to meet their scholarly activity requirements. About Children's Mercy Children's Mercy is one of the United States' leading non-profit, independent pediatric health systems, offering a comprehensive suite of departments, centers, and clinics. Founded in 1897, Children's Mercy is dedicated to holistic care, impactful research, breakthrough innovation and educating the next generation of caregivers. Guided by our mission, vision and values, our aim is to create a world of wellbeing for all children. Children's Mercy is consistently ranked among the best children's hospitals in the nation by US News & World Report, and we were the first hospital in Missouri or Kansas to receive Magnet designation for excellence in patient care from the American Nurses Credentialing Center - an honor we have received five consecutive times. Some Children's Mercy facts and figures: 390 licensed beds (63 PICU/CICU, 81 NICU) Nearly 800 faculty Over 50 specialties 600,000 total visits 190,000 emergency and urgent care visits 20,000 surgical cases Primary service area includes150 counties in Missouri and Kansas Level 1 Children's Surgery Center by the American College of Surgeons Only pediatric Level 1 Trauma Center between St. Louis and Denver Comprehensive solid organ transplant center with sustained, exceptional outcomes Education Education is a core tenet of Children's Mercy. Children's Mercy provides education opportunities to nursing students, medical students, residents and fellows, supporting over 1,400 learners annually. Children's Mercy is the pediatric clerkship site for both UMKC and KU medical students and provides elective rotations and sub-internships to students at any accredited allopathic or osteopathic medical school. Children's Mercy is highly active in Graduate Medical Education with accredited residencies in pediatrics, med/peds, child neurology, pediatric dentistry, pediatric optometry and pharmacy. Children's Mercy offers more than 40 fellowship programs across numerous areas, developing the next generation of subspecialists. Certificate and master's programs are also operated in conjunction with its academic partners, the University of Kansas (KU) and the University of Missouri - Kansas City (UMKC). Finally, our robust clinical training resources are augmented by research opportunities for learners at all levels. Research Children's Mercy is dedicated to becoming a leader in pediatric research. A directed strategic planning initiative established the Children's Mercy Research Institute (CMRI) to focus on research and research infrastructure. Through the generosity of two philanthropic gifts totaling $150 million, the hospital constructed a nine story, 375,000 square foot research facility to provide scientists with state-of-the-art technology. In addition, these generous gifts help support funding for scientific programs and recruitment. Research conducted today includes basic, translational, and clinical research in numerous areas including pharmacology, cancer, cardiology, genetic diseases and health outcomes. Areas of research strength include Precision Therapeutics, Genomic Medicine, Population Health, Emerging Pathogens and Innovations in Health Care Delivery. Beyond these areas of emphasis, Children's Mercy and the CMRI also provide encompassing resources for Children's Mercy faculty to pursue research, from developing a research question, biostatistical planning, grant application and management, and coordination of clinical trials. About Kansas City Crossing into both Missouri and Kansas, the Kansas City Metropolitan Area is an affordable and comfortable place to live and raise a family. The metro's anchor city, Kansas City, Missouri, is the largest city in the state and has great museums, a busy downtown, multiple professional sports franchises, an exciting music scene and many charming neighborhoods. Throughout the Metro area, you will find highly ranked public schools, beautiful parks and other green spaces, and lots of amazing people. Kansas City is large enough to provide the amenities of a metropolitan area, while small enough to allow for easy commutes, assessable amenities and a very high quality of life. Ideal Qualifications and Experience MD/DO or MD/PhD is required Current academic rank of Associate Professor or Professor A strong record of academic achievement as evidenced by external funding and publications Strong interpersonal skills and a track record of partnership across subspecialties and disciplines Commitment to education of learners at all levels Demonstrated interest in advancing research as it pertains to division activities and interactions with the broader Children's Mercy community and beyond A commitment to our true north pillars: quality and safety, connected experience, strategic goals, stewardship, people and Fosters and models our values: kindness, curiosity, inclusion, team and, integrity A deep commitment to fostering and supporting programs that address equity, inclusion and, diversity Nominations and Applications (cover letter and curriculum vitae) should be submitted via e-mail to: Attention: Search Committee Co-Chairs, Keith August, MD, MS, () and Amanda Nedved, MD, () All materials will be treated as confidential. Children's Mercy is an Equal Opportunity/Affirmative Action Employer. For additional information, please visit our website at .

The Department of Pediatrics at Children's Mercy (CM) seeks to recruit a creative and scholarly leader to serve as the founding Division Director of our newly established Division of Molecular Oncology & Cellular Therapeutics (MOCT). In close partnership with the Division of Clinical Hematology, Oncology and Bone Marrow Transplant (CHOT), MOCT is the academic home for discovery and translational science in the field of hematology/oncology/transplant. The Division Director will be an influential leader who will expand our current laboratory-based research programs and collaborate with faculty members in CHOT to develop new diagnostic and treatment options for pediatric and young adult hematology and oncology patients. There are currently five principal investigators in MOCT. Funded research includes tumor suppressor pathways, glioblastoma, diffuse midline glioma, infant and other high-risk leukemias, leukemia stem cells, immunogenic cell death and mitigation of acute and delayed radiation exposure. In addition to augmenting existing research programs, a major area of emphasis for the Division Director will be to recruit experienced scientists whose expertise is additive to the entire division and who have a passion for mentoring the next generation of scientists. Children's Mercy is fortunate to have five available endowed chairs for established scientists whose work is directly relevant to immunotherapy and pediatric malignancies. It is anticipated that the Division Director of MOCT will be appointed to one of these Chairs, with the remaining to be used for strategic recruitments. In addition to CHOT, the Division Director will collaborate internally with the Genomic Medicine Center (GMC) and the Genomics Laboratory (Department of Pathology and Laboratory Medicine, DPLM), both of which provide advanced cancer genomic sequencing for clinical and research applications. Routine management of all newly diagnosed patients with cancer includes clinical tumor and deep exome germline DNA sequencing using state-of-the-art short-read sequencing on the Illumina NovaSeqX platformed in the GMC. The GMC also performs clinical and research molecular characterization of tumor and germline specimens including advanced sequencing technologies, such as CLIA- and CAP-compliant long-read read 5-base sequencing (HiFi-GS). Furthermore, functional characterization of cells and tissues is facilitated by research platforms including single-cell sequencing, chromatin and RNA-seq. In addition, the GMC has a research platform for patient-derived organoids. The DPLM provides a full clinical molecular testing suite including cytogenetics, pharmacogenetics, clinical microarray, and optical mapping. Externally, the Division Director will facilitate connections between the Children's Mercy Research Institute (CMRI) and regional research institutions to collaborate on innovative discovery and translational research. CM is the pediatric partner in the NCI-designated Kansas University Comprehensive Cancer Center (KUCCC) and has active research collaborations with both the KUCCC and the Stowers Institute for Medical Research. To achieve the vision of a national-recognized research program, approximately 7,000 square feet of contiguous space is available for programmatic expansion in the CMRI, including wet bench laboratory space, adjacent faculty offices, graduate student and post-doctoral fellow cubicles, and shared equipment bays and rooms. Immunotherapeutics and cellular therapy are also significant opportunities for research and programmatic development. Our vision to lead in the field influenced the construction of a 3,000 square feet GMP facility adjacent to the laboratory space in the CMRI building. We aim to expand discoveries from immunotherapeutics research towards improved cancer treatments and refined management of both solid organ transplantation and diseases of immunologic origin. The foremost qualities necessary for this position are a compelling vision for discovery and translational research in hematology, oncology, bone marrow transplant, and cellular therapy (H/O/B/CT). The successful candidate will have a strong track record of academic achievement evidenced by sustained extramural funding and a desire to build a division that will be recognized as a national leader. Other desired characteristics include successful associations with NCI Comprehensive Cancer Centers and a commitment to advancing a culture of high accountability and collaboration. The individual selected for this position will be a strategic and highly communicative leader who holds PhD, MD/PhD or MD credentials. About the Clinical Program. CHOT is divided into 3 sections - Hematology, Oncology, and BMT (H/O/B). CHOT has a long-standing clinical fellowship in H/O/B, an advanced fellowship in pediatric coagulation and an advanced research fellowship for trainees committed to a research-intensive career path. The Hematology Section has active programs in coagulation, sickle cell and general hematology. The Kansas City Regional Hemophilia Treatment Center is among the 5 largest in the country and is a 340B program. The Comprehensive Sickle Cell Program cares for over 300 children, and our hematologists oversee the Anticoagulation Management Team and the Coagulation Consult Service, staff the Vascular Anomalies Specialty Clinic, and co-direct the Pediatric Stroke team The Oncology Section has programs focused on specific cancers, patient populations & diagnostics, and therapeutics. Faculty (MD/DO/PhD) within and outside the Division have a growing presence in cancer research with current focus and grant support in cancer genomics, cancer biology, experimental therapeutics, immunotherapeutics and the impact of ethnic diversity on treatment outcomes. CM is an active COG institution and a member of the COG Pediatric Early Phase-Clinical Trial Network (PEP-CTN). The Blood & Marrow Transplantation/Cellular Therapy Section is both FACT- and COG-accredited, and we are a regional referral center for BMT of off-trial patients. The program shares a stem cell processing lab with the KUCCC adult BMT program, one of the largest in the country. The lab is capable in all stem cell source transplants including related, unrelated, matched, mismatched, T-cell depleted, haplo-identical, bone marrow, peripheral blood and umbilical cord blood. Building on the early cellular therapy discovery efforts at CM, the program can perform complicated graft manipulation for either clinical or research endeavors. Further details for all aspects of CHOT may be found on the CMH H/O/BMT webpages which includes over 10 years of Cancer Center Annual reports: About Children's Mercy Children's Mercy is a nationally recognized, free-standing children's hospital founded in 1897 to provide care for poor and ill children of Kansas City. As a freestanding, independent children's hospital, CM provides comprehensive pediatric care across the spectrum of primary to quaternary care delivered by 750 doctors in more than 40 subspecialties. Our primary service area encompasses 150 counties in Missouri and Kansas. In 2023, CM conducted nearly 600,000 total visits, including 55,000 telemedicine visits, almost 204,000 emergency and urgent care visits, and 20,000 surgical cases. CM is one of only ten centers in the nation verified as a Level 1 Children's Surgery Center by the American College of Surgeons and the only pediatric Level I Trauma Center in the region. CM has been ranked consistently by U.S. News & World Report in the top 50 of all ten assessed pediatric subspecialties. We enthusiastically complement our nationally-ranked subspecialty care with robust community support programs that keep kids safe and healthy. Education CM is the pediatric clerkship site for both UMKC and KU medical students. Graduate medical education supports over 1,400 trainees annually, with accredited residencies in pediatrics, med/peds, child neurology, pediatric dentistry, pediatric optometry and pharmacy. We have over 40 fellowship programs, provide training for psychology interns and post-doctoral fellows, and have post-doctoral PhD scientists in clinical and laboratory-based research programs. Research Children's Mercy is dedicated to improving the health and well-being of children through engagement in world-class, collaborative translation research. Through the generosity of two substantial philanthropic gifts, in 2020 CM opened a nine story, 375,000 square foot facility providing scientists access to state-of-the-art technology with ample dry and wet lab spaces. These generous gifts and many others support enhancement of scientific programs and targeted recruitment. Research conducted today includes basic, translational and clinical research across many pediatric subspecialties. Areas of strength include Precision Therapeutics, Genomic Medicine, Population Health and Emerging Infections. CM holds a T32 training grant in Pediatric Clinical Pharmacology and is an impactful member of the Frontiers Clinical and Translational Science Institute (CTSI) at the University of Kansas. This regional CTSI program comprises four universities (including three medical schools) and three health systems on both sides of the Missouri-Kansas state line. About Kansas City: The Kansas City Metropolitan Area is an affordable and comfortable place to live and raise a family. The metro's anchor city, Kansas City, Missouri, is the largest city in Missouri and has many great museums, a busy downtown, multiple professional sports franchises, an exciting music scene and many charming neighborhoods. The metro area includes four of the seven largest cities in Kansas, including Kansas City (Kansas), Overland Park and Olathe. Kansas City is large enough to provide the features of a metropolitan area, but still allows for easy commutes . click apply for full job details

The Department of Pediatrics at Children's Mercy seeks a creative and scholarly leader to serve as Division Director of of Health Services and Outcomes Research (HSOR). The Division Director will be responsible for leading the educational, research and quality missions of HSOR, an academic division focused on conducting high quality, impactful research that leads to improved health outcomes and reduced health disparities for children and families. The Division Director will foster collaborative ties with the whole of the pediatric enterprise to ensure the welfare and improve the health of the children in the region. This is a clinical faculty position offering academic appointments at the University of Missouri - Kansas City School of Medicine and the Kansas University School of Medicine, rank to be commensurate with experience. The foremost quality necessary for this position is vision for the field of health outcomes research. Other desired characteristics include 1) a track record of developing young investigators into independent scientists; 2) interest in academic infrastructure and research finances; 3) successful collaborations with administration, hospital, medical, and research partners; 4) unwavering commitment to the principles of diversity, equity and inclusion; and 5) developing a culture of high team accountability and professionalism. The individual selected for this position will be a strategic and highly communicative leader with a doctoral degree (MD/DO/PhD). As Division Director of HSOR, the individual reports to the Chair of Pediatrics. HSOR faculty and staff are experts in community engaged health research; health communication; Diversity, Equity and Inclusion research; behavioral obesity discovery and intervention research; and computational approaches to draw insights from large and diverse data sets. HSOR is also home to the Biostatistics and Epidemiology Core (BEC), the Community Engaged Research Team, and the Formative Research Team (FRT). Established in 2013, HSOR has quickly developed a national and international reputation for impactful translational science that reduces health disparities. The BEC is a team of biostatisticians (faculty and staff) who collaborate with researchers at Children's Mercy to apply their range of expertise in study design and analytic methods including: multi-level and mixed modeling, latent variable modeling, longitudinal models, survival analysis, patient reported outcomes, clinical trial design, and statistical genomics. The Community Engaged Research Team facilitates the CMRI Community and Youth Research Advisory Boards to promote equitable community-research partnerships and collaborates with researchers and community partners to ensure that studies address community priorities and utilize patient, caregiver, and community centered recruitment, data collection, and dissemination methods. The Formative Research Team (FRT) consults and collaborates with researchers to design studies grounded in social and behavioral theory; design and conduct rigorous in-depth interviews, focus-groups, and surveys; analyze qualitative data; and disseminate and integrate findings into interventions and their evaluations. Through strategic team science collaboration with colleagues locally, nationally and internationally, HSOR has leveraged Children's Mercy strengths in clinical care, genomics, and clinical pharmacology to improve care, enhance research and speed translation of best practice. About Children's Mercy Children's Mercy is one of the United States' leading non-profit, independent pediatric health systems, offering a comprehensive suite of departments, centers, and clinics. Founded in 1897, Children's Mercy is dedicated to holistic care, impactful research, breakthrough innovation and educating the next generation of caregivers. Guided by our mission, vision and values, our aim is to create a world of wellbeing for all children. Children's Mercy is consistently ranked among the best children's hospitals in the nation by US News & World Report, and we were the first hospital in Missouri or Kansas to receive Magnet designation for excellence in patient care from the American Nurses Credentialing Center - an honor we have received five consecutive times. Some Children's Mercy facts and figures: 390 licensed beds Nearly 800 faculty >50 specialties 600,000 total visits 190,000 emergency and urgent care visits 20,000 surgical cases Primary service area encompasses 150 counties in Missouri and Kansas Level 1 Children's Surgery Center by the American College of Surgeons Only pediatric Level 1 Trauma Center between St. Louis and Denver Comprehensive solid organ transplant center with sustained, exceptional outcomes Education Education is a core tenet of Children's Mercy. Children's Mercy provides education opportunities to nursing students, medical students, residents and fellows, supporting over 1,400 learners annually. Children's Mercy is the pediatric clerkship site for both UMKC and KU medical students, and provides elective rotations and sub-internships to students at any accredited allopathic or osteopathic medical school. Children's Mercy is highly active in Graduate Medical Education with accredited residencies in pediatrics, med/peds, child neurology, pediatric dentistry, pediatric optometry and pharmacy. Children's Mercy offers more than 40 fellowship programs across numerous areas, developing the next generation of subspecialists. Certificate and masters programs are also operated in conjunction with its academic partners, the University of Kansas (KU) and the University of Missouri - Kansas City (UMKC). Finally, our robust clinical training resources are augmented by research opportunities for learners at all levels. Research Children's Mercy is dedicated to becoming a leader in pediatric research. A directed strategic planning initiative established the Children's Mercy Research Institute (CMRI) to focus on research and research infrastructure. Through the generosity of two philanthropic gifts totaling $150 million, the hospital constructed a nine story, 375,000 square foot facility provide scientists state-of-the-art technology. In addition, these generous gifts help support funding for scientific programs and recruitment. Research conducted today includes basic science and clinical research in numerous areas including pharmacology, cancer, cardiology, genetic diseases and health outcomes. Areas of research strength include Precision Therapeutics, Genomic Medicine, Population Health, Emerging Pathogens and Innovations in Health Care Delivery. Beyond these areas of emphasis, Children's Mercy and the CMRI also provide encompassing resources for Children's Mercy faculty to pursue research, from developing a research question, biostatistical planning, grant application and management, and coordination of clinical trials. About Kansas City: Crossing into both Missouri and Kansas, the Kansas City Metropolitan Area is an affordable and comfortable place to live and raise a family. The metro's anchor city, Kansas City, Missouri, is the largest city in the state and has great museums, a busy downtown, multiple professional sports franchises, an exciting music scene and many charming neighborhoods. Throughout the Metro area, you will find highly ranked public schools, beautiful parks and other green spaces, and lots of amazing people. Kansas City is large enough to provide the amenities of a metropolitan area, while small enough to allow for easy commutes, assessable amenities and a very high quality of life. Ideal Qualifications and Experience An MD/DO/PhD or equivalent is required Current academic rank of Associate Professor or Professor A strong record of clinical and academic achievement in health care sciences Demonstrated interest in advancing research as it pertains to division activities and interactions with the broader Children's Mercy community A commitment to our true north pillars: quality and safety, people, patient experience, delivery and stewardship Fosters and models our values: kindness, curiosity, inclusion, team and integrity A deep commitment to fostering and supporting programs that address equity, inclusion and diversity A track record of partnership with academic medical centers Strong interpersonal skills and the ability and commitment to collaborate with leadership at partner institutions Nominations and Applications (cover letter and curriculum vitae) should be submitted via e-mail: Attention: Drs. Matt McLaughlin and Shayla Sullivant, Search Committee Co-Chairs All materials will be treated as confidential. Children's Mercy is an Equal Opportunity/Affirmative Action Employer. For additional information, please visit our website at .

DIVISION DIRECTOR - NEUROLOGY, CHILDRENS MERCY KANSAS CITY, MO The Department of Pediatrics at Childrens Mercy (CM) seeks to recruit a creative and scholarly leader to serve as Division Director of Neurology. The Division of Neurology is a nationally recognized leader in comprehensive pediatric neuroscience care, education, and research. The ideal Division Director will bridge the Divisions past and present successes with the possibilities that await its future, forging a bold vision for the years to come. The Division of Child Neurology has experienced a decade of significant growth and anticipates continued expansion. Over the past 18 years, the division has grown from a five-provider, epilepsy-focused service into a vibrant, multidisciplinary program comprising 25 physicians, 20 nurse practitioners, 23 staff nurses, and two nurse coordinators. The Division has substantial expertise in a broad range of neurological subspecialties, delivering expert, evidence-based care to a growing regional and national patient population. In 2024, our team completed over 22,000 patient visits, including nearly 7000 new patient evaluations. We are proud to be ranked nationally by U.S. News & World Report in pediatric neurology and neurosurgery, underscoring our focus on clinical excellence, innovation, and access to care. Specialized Clinical Programs and Procedures Division of Pediatric Neurology Mission Statement: Through innovation, collaboration, and unwavering commitment to excellence, the Division of Neurology at Childrens Mercy continues to redefine whats possible in pediatric neuroscience. We operate nationally accredited and recognized centers and subspecialty clinics, including: Level 4 Epilepsy Center: As a member of the National Association of Epilepsy Centers, we offer high-volume epilepsy surgery, ketogenic diet therapy, vagal nerve stimulation (VNS), and intracranial EEG monitoring. We are one of the largest pediatric neuromodulation centers in the U.S., with over 2,000 children with VNS devices. We actively engage in data mining efforts to evaluate efficacy, side-effect profiles, and programming best practices for VNS. Epilepsy patients are evaluated in one of two Epilepsy Monitoring Units, depending on acuity. Our surgical EMU prioritizes patients undergoing SPECT, PET, or other evaluations needed to determine next steps in care for refractory epilepsy. Multidisciplinary clinics provide coordinated care for first-time seizures, tuberous sclerosis and neurofibromatosis, Dravet syndrome, and ketogenic diet treatment. Comprehensive Movement Disorder & Spasticity Program: Multidisciplinary spasticity and tone clinic involving neurology, rehabilitation, neurosurgery, orthopedics, pharmacy, and nurse coordinators. Evaluation and procedural planning for selective dorsal rhizotomy, intrathecal baclofen pump placement, and orthopedic interventions. Active Deep Brain Stimulation (DBS) program, which includes a pre-surgical multidisciplinary DBS clinic and ongoing programming follow-ups. Headache and Pain Program: Six advanced practice providers credentialed in procedures such as basic and advanced acupuncture, occipital and pericranial nerve blocks, and botulinum toxin for migraine. Two board-certified headache medicine physicians with comprehensive procedural privileges across all headache interventions. Neonatal Neurology Program:A team of four pediatric neurologists, with expertise in epilepsy and stroke, see consults in the NICU for a broad range of conditions including hypoxic ischemic injury, structural brain abnormalities, and genetic differences. Collaborative care is provided to families being seen in the Fetal Health Center as part of a multidisciplinary team. Patients seen by the Neuro/NICU team in the hospital are followed in a specialized clinic for one year, ensuring excellent continuity of care. Research Vision and Active Projects We have transformed into a research-active division, aligning clinical innovation with scientific discovery. Over the last five years, we secured over $6M in extramural funding and implemented a strategic vision supporting physician-scientists and clinically focused faculty. Flagship Research Projects: Pharmacogenomics of Dystonia Treatment (NIH K23HD114899-01A1): A five-year study, led by Dr. Gelineau-Morel, investigating genetic influences on trihexyphenidyl metabolism in children with dystonia and cerebral palsy. This project aims to develop a precision dosing model to personalize treatment. Diagnostic Biomarkers for Dystonia in Cerebral Palsy (Pediatric Epilepsy Research Foundation): Focused on creating an imaging registry and performing lesion network mapping to validate brain networks implicated in acquired dystonia. Development of R-Trihexyphenidyl for Pediatric Dystonia (Mercy Research Partners): A translational project collaborating with pharmaceutical partners to bring a more targeted form of trihexyphenidyl to clinical trials. Hypoxic Ischemic Encephalopathy and Acquired Dystonia (HEAD): Ongoing imaging research into the brain networks affected in children with acquired dystonia. Angelman Syndrome Research Platform (Angelman Syndrome Foundation and the Foundation for Angelman Syndrome Therapeutics): Accredited Angelman Syndrome Clinic Collaborative movement disorder study with Boston Childrens, Rush, and Vanderbilt, supported by an Angelman Syndrome Foundation grant. Participation in multiple ASO phase II and III trials for various genotypes. Development of brain organoid models and single-cell whole genome sequencing of cortical dysplasia tissue to identify surgical and pharmacologic biomarkers (multi-divisional and -departmental collaboration across CM) Tuberous Sclerosis MO (Missouri Dept. of Mental Health): Collaborative project with Washington University in St. Louis. Quality Improvement in Epilepsy Care (HRSA) : The REACT, REACT extension and TRACT studies are quality improvement research projects aimed at children with epilepsy living in Kansas and Missouri. Education and Training Excellence Our training programs are a cornerstone of our division. Each year we train 12 fellows in child neurology and one fellow each in epilepsy, headache, and neuropsychology. We emphasize scholarly productivity, expecting national presentations and supporting peer-reviewed publications from all fellows. Our graduates have consistently passed board exams and joined academic institutions nationwide. A major area of emphasis for the next Division Director will be to continue to innovate in the field of Child Neurology. Building on a busy clinical program and growing research profile, the Division Director will advance the academic growth of the faculty, recruit aspiring investigators and foster an environment that encourages world class clinical care and new discoveries that advance the field. Current areas targeted for future emphasis include: Developing a neuropsychiatry clinic with emphasis on Tourette syndrome, psychogenic epilepsy, and neuromodulation for refractory psychiatric disorders. Developing a neuromuscular program. Continuing to support research with utilization of internal funding mechanisms to lead to competitive extramural proposals Expanding our national reputation through research output, high-quality care, and additional subspecialty clinic accreditations. About Childrens Mercy Childrens Mercy is a nationally recognized, free-standing childrens hospital founded in 1897 to provide care for poor and ill children of Kansas City. As a freestanding, independent childrens hospital, CM provides comprehensive pediatric care across the spectrum of primary to quaternary care delivered by 750 doctors in more than 40 subspecialties. Our primary service area encompasses 150 counties in Missouri and Kansas. In 2023, CM conducted nearly 600,000 total visits, including 55,000 telemedicine visits, almost 204,000 emergency and urgent care visits, and 20,000 surgical cases. CM is one of only ten centers in the nation verified as a Level 1 Childrens Surgery Center by the American College of Surgeons and the only pediatric Level I Trauma Center in the region. CM has been ranked consistently by U.S. News & World Report in the top 50 of all ten assessed pediatric subspecialties. We enthusiastically complement our nationally-ranked subspecialty care with robust community support programs that keep kids safe and healthy. Education CM is the pediatric clerkship site for both UMKC and KU medical students. Graduate medical education supports over 1,400 trainees annually, with accredited residencies in pediatrics, med/peds, child neurology, pediatric dentistry, pediatric optometry and pharmacy. We have over 40 fellowship programs, provide training for psychology interns and post-doctoral fellows, and have post-doctoral PhD scientists in clinical and laboratory-based research programs. Research Childrens Mercy is dedicated to improving the health and well-being of children through engagement in world-class, collaborative translation research. Through the generosity of two substantial philanthropic gifts, in 2020 CM opened a nine story, 375,000 square foot facility providing scientists access to state-of-the-art technology with ample dry and wet lab spaces. These generous gifts and many others support enhancement of scientific programs and targeted recruitment. Research conducted today includes basic, translational and clinical research across many pediatric subspecialties. Areas of strength include Precision Therapeutics, Genomic Medicine, Population Health, Emerging Infections, and Innovations in Health Care Delivery. CM holds a T32 training grant in Pediatric Clinical Pharmacology and is an impactful member of the Frontiers Clinical and Translational Science Institute (CTSI) at the University of Kansas . click apply for full job details

Pediatric Sickle Cell Program Director The Division of Hematology/Oncology/Bone Marrow Transplantation (BMT) is seeking a new faculty member to lead our Sickle Cell Program. Applicants must possess a medical degree and have certification in Pediatric Hematology/Oncology. The ideal candidate will have at least three years of post-fellowship experience in treating patients with Sickle Cell Disease. The primary responsibility of this position is to provide excellent clinical care for children and adolescents with Sickle Cell Disease. We are seeking a visionary leader with clinical, academic, research, and education experience. Childrens Mercy Kansas City has a full-service sickle cell program that follows approximately 300 patients from infancy until 21 years of age. This program has a full complement of staffing including one other faculty physician, two advance practice nurses, a social worker, psychologist, research nurse, and data manager. We are a regional center for Missouri and have been actively involved in many NIH and industry clinical trials. The Division of Hematology/Oncology/BMT has a robust coagulation service and is a Hemophilia Treatment Center. We see approximately 200 newly diagnosed children with cancer every year and perform 35-40 transplants annually. The entire division has 24 attendings and at least 6 fellows. The successful applicant must share our unwavering commitment to excellence, integrity, collegiality, antiracism, and respect for inclusion of individuals with diverse backgrounds. Please send CV and cover letter to: Please direct questions to: Shannon Carpenter, MD, MS, Division of Hematology/Oncology, Professor

The Children's Mercy Kansas City Division of Adolescent and Young Adult Medicine is seeking a fellowship-trained, BC/BE Adolescent and Young Adult Medicine specialist to join the faculty. The duties of this full-time position are primarily as an academic clinician educator and/or clinician-researcher. The Division of Adolescent and Young Adult Medicine (AYAMed) includes 6 adolescent and young adult medicine trained specialist faculty, 1 faculty pediatrician with eating disorder expertise, up to 3 fellows, 2 eating disorder nurse practitioners, a clinical pharmacogenomics PhD researcher/nurse practitioner, Title X Director/nurse practitioner, social workers, staff nurses, care assistants, and clinical research coordinators. This team provides outpatient care at 4 Children's Mercy clinic locations in metro Kansas City, as well as Synergy Services, for unhoused youth. Each core AYAMed clinic is part of a robust Title X program supporting comprehensive reproductive health care services. Providers work alongside colleagues in several multidisciplinary specialty clinics providing care to adolescents and young adult (AYA) patients typically to age 22 years of age. These clinics include: Eating Disorders Center, Gender Pathways Services, Medical Adolescent PCOS Program, and Complex Syncope Clinic among others. Inpatient consultations are provided at 2 Kansas City area Children's Mercy Hospitals. Our faculty include 2 K-23 Awarded faculty researchers and multiple research projects and programs across a vast array of research within the Children's Mercy Research Institute. CMKC provides each Division and project with a Research Business Partner to help shepherd concepts to funding, implementation, and completion. There is a medical writing center to support publication, and dissemination. Resources on-site include our Office of Research Business Management and Medical Writing Center. These resources serve as the centralized support for the financial and business management for a Principal Investigator's portfolio of funds which includes sponsored projects, gifts, endowments, startups, and residuals at Children's Mercy. This hands-on approach provides guidance and oversight for the fiscal stewardship of research activities and for compliance with sponsor requirements, government regulations and hospital policies. Please apply with CV and Cover Letter using link below or send to . The successful applicant must share our unwavering commitment to excellence, integrity, collegiality, antiracism, and respect for inclusion of individuals with diverse backgrounds.